Singapore: Sihuan Pharmaceutical entered into a collaboration agreement with NeuroVive Pharmaceutical to develop two in...
Singapore: Australian company Bioxyne closed its 320-patient study, which was designed to evaluate the efficacy and safe...
Singapore: MicuRx Pharmaceuticals, a privately-held biopharmaceutical company developing next-generation antibiotics, ha...
Singapore: MedImmune, the global biologics R&D arm of AstraZeneca, has entered into a three-year collaboration with ...
Singapore: Belgium based pharmaceutical company UCB and global pharmaceutical company, Biogen, have entered into an agre...
Singapore: BD Biosciences, a global medical technology company, has launched BD LSRFortessa X-20 Cell Analyzer, to deliv...
Singapore: Assistant Professor (Dr) Robert H I Andtbacka presented a summary of his ongoing study with Viralytics' Cavat...
Singapore: India-based Orchid Pharma entered into a strategic partnership with Europe-based Allecra Therapeutics to deve...
Singapore: CoDa Therapeutics has raised an additional $19.8 million (NZ$24.5 million) from Russian investment firm Rusna...
Singapore: Japanese multinational Chugai Pharmaceutical has filed a new drug application to the Ministry of Health, Labo...
Singapore: Viralytics reported strong interim results from its phase II clinical trial of Cavatak treatment in late stag...
Singapore: The global pre-diabetes population is three times the size of the current diabetes patient population and the...
Singapore: Genzyme, a Sanofi company, received approval from the US FDA for AUBAGIO (teriflunomide) as a new once-daily,...
Singapore: Taiwan's TaiGen Biotechnology has submitted New Drug Application (NDA) for the oral formulation of nemonoxaci...
Singapore: Illumina announced that Teva Pharmaceutical has signed an exclusive agreement with Verinata Health, an Illumi...
Singapore: Global biopharmaceutical firm Merck Serono has initiated international Phase III trial of its investigational...
Singapore: Boehringer Ingelheim has recieved Euroean approval for Pradaxa (dabigatran etexilate) for the treatment and p...
Singapore: AstraZeneca has formed collaboration with Korea's LegoChem Biosciences to develop a novel antibiotic to treat...
Singapore: Drug resistance and patent expiries are demanding that the antibacterial drug market moves forward soon, but ...
Singapore: Cancer Therapeutics, an Australian company focused on translating cancer biology research into novel treatmen...
Singapore: The WHO has prequalified Eisai's drug NTD002, a 100 mg tablet of diethylcarbamazine (DEC) for treatment of el...
Singapore: Bayer's Stivarga (regorafenib) became the second drug to have been approved in the past two months by the US ...
Singapore: CSL has developed a new drug candidate that is able to prevent the development of type 2 diabetes and revers...
Singapore: Novartis oncology president, Mr Hervé Hoppenot, has stepped down from the position to pursue a career oppo...
Singapore: Hodgkin lymphoma survivors, who received certain radiation and chemotherapy regimens, were at increased risk ...
Singapore: A study by Janssen Research and Development revealed that patients with active psoriatic arthritis, who were ...
Singapore: Swiss chemicals and drug company Lonza and USA-based BioWa, a wholly-owned subsidiary of Japan's Kyowa Hakko ...
Singapore: A joint panel of members from the Gastrointestinal Drugs and Drug Safety and Risk Management Advisory Committ...
Singapore: Australia Patrys, a clinical stage biopharmaceutical company, has received approval to commence its planned P...
Singapore: Novartis and Malaria No More, a leading global charity to end malaria deaths, are joining forces on the Power...
Singapore: An experimental treatment for alcohol dependence works better in individuals who possess specific combination...
Singapore: Merck has partnered with Kenya Medical Research Institution (KEMRI) for scientific research and development p...
Singapore: Shionogi, one of Japan's biggest pharmaceutical companies, has signed a memorandum of understanding (MoU) for...
Singapore: Merck, which is known as MSD outside the US and Canada, revealed positive results from its phase Ib study sho...
Singapore: Viralytics has finalized the clinical study report on the phase I evaluation of Cavatak, which is administere...
Singapore: US based Forest Laboratories plans to acquire exclusive rights in the United States for Saphris (asenapine) s...
Singapore: The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's vaccine MenHibrix (meningococcal gr...
Singapore: Australia-based Patrys, a clinical stage biotechnology company, has been granted a second Australian patent f...
Singapore: Vanderbilt University, US, and Bristol-Myers Squibb signed a collaboration agreement for the R&D and comm...
Glenmark Pharmaceuticals USA (Glenmark) has been granted final approval by the United States Food and Drug Administratio...
Singapore: It has taken the lupus research community over 50 years to produce a new therapy. Although it is now a year o...
Singapore: A study conducted by Beike Biotechnology Company in conjunction with physicians and researchers at two Chines...
Singapore: Autism results from abnormal cell communication. Testing a new theory, researchers at the University of Calif...
Singapore: Boehringer Ingelheim and the Institute of Molecular Health Science and the Institute of Food, Nutrition and H...
Singapore: A new study by researchers at Columbia University Medical Center, US, revealed that injection of triglyceride...
Singapore: Dicerna Pharmaceuticals, a RNA interference (RNAi) company focused on developing breakthrough oncology thera...
Singapore: Celgene has discontinued treatment with Revlimid (lenalidomide), prescribed for for multiple myeloma, in open...
Singapore: Bristol-Myers Squibb has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Devices...
Singapore: Daiichi Sankyo has appointed Dr Glenn Gormley, as president and chairman of Daiichi Sankyo, US. Dr Gormley w...
Singapore: Health Sciences Authority (HSA) in Singapore has approved new treatment, apixaban (Eliquis), marketed by phar...
Singapore: Australia medical biotechnology company, Innate Immunotherapeutics, plans to raise up to $10.93 million (A$12...
Singapore: Shanghai SynTheAll (STA) Pharmaceutical, subsidiary of WuXi PharmaTech, a leading pharmaceutical, biotechnolo...
Singapore: BHR Pharma has started recruiting patients, who are suffering from severe traumatic brain injury (TBI), for t...
Singapore: Japan-headquartered Astellas Pharma and Ambit Biosciences have initiated the phase IIb open-label clinical tr...
Sample preparation is a daily function in any life science research or drug discovery lab and pipetting is a fundamental...
Singapore: Bayer HealthCare has stopped its phase II/III study testing its experimental treatment BAY 86-6150 on certain...
Singapore: Boehringer Ingelheim has submitted a marketing authorization application to the European Medicines Agency (EM...
Singapore: SFJ Pharmaceuticals, primarily focused on funding and executing phase III studies of drugs, has entered into ...
Singapore: Bristol-Myers Squibb has discontinued the development of BMS-986094 (formerly known as INX-189), a nucleotide...
Singapore: Bayer HealthCare has recieved US FDA approval for Adempas (riociguat) tablets for the treatment of adults wit...
Singapore: Genzyme, a Sanofi company, received a Refuse to File letter from the US FDA in response to the supplemental B...
Singapore: The National Institutes of Health (NIH) is funding $45 million for research aimed at preventing Alzheimer's ...
Singapore: Singapore's emerging company Clearbridge BioMedics plans to launch its ClearCell FX System at American Societ...
Singapore: The US Food and Drug Administration (FDA) has accepted Australia-based CSL Behring's biologics license applic...
Singapore: Japan-based biopharmaceutical firm, Kyowa Hakko Kirin (KHK) has setup Singapore Translational Research Labora...
Singapore: AB Sciex, a global leader in analytical technologies, has launched MasterView Software, a new software applic...
Singapore: Australia-based Living Cell Technologies (LCT) has implanted regenerative cell therapy NTCELL, a treatment fo...
Singapore: GlaxoSmithKline's (GSK) Dermai study, a phase III, randomized, blinded, placebo-controlled Mage-A3 cancer imm...
Singapore: The Health Sciences Authority (HSA) of Singapore has approved Bayer' Stivarga, the first oral targeted therap...
Singapore: European Forum Against Blindness (EFAB) has revealed the results of a six-country study which analyzed the ec...
Singapore: Gilead Sciences has submitted a New Drug Application (NDA) to the US FDA for approval of sofosbuvir, a once-d...
Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, ...
Bangalore: Advinus Therapeutics, a Bangalore-based drug discovery and development company, and P2D Bioscience, a CNS-foc...
What is Glivec?Glivec or imatinib mesylate is the first of a class of drugs that specifically inhibits a target enzyme, ...
Singapore: A new report by healthcare experts GlobalData has revealed that on cytomegalovirus (CMV), which is generall...
Singapore: Israel-based Sol-Gel Technologies achieved positive results for a phase II trial in the US targeting mild-to-...
Singapore: The Indian Ministry of Health and Family Welfare has notified the draft rules on a new domain of medicines ca...
Singapore: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted...
Singapore: The US FDA has cancelled an advisory committee meeting that was scheduled to be held on July 18, 2013, in ord...
Singapore: Patrys, a clinical stage biopharmaceutical company, has confirmed anti-cancer properties of PAT-SM6 and has d...
Singapore: Agilent Technologies and US-based SomaLogic have entered into an agreement to expand access to SomaLogic's un...
Singapore: Boehringer Ingelheim and Eli Lilly and Company received approved from the US FDA for a supplemental new drug ...
Singapore: Regeneron Pharmaceuticals and Sanofi have been asked by the US FDA to assess potential neurocognitive side ef...
Singapore: Taiwan-based TWi Biotechnology has received notification of patent allowance for AC-201, its lead drug candid...
Singapore: Nasopharyngeal carcinoma (NPC) is a rare form of cancer in Western Europe and North America and is emerging a...
Singapore: A clinical drug for Huntington's and Alzheimer's disease by Australia-based Prana Biotechnology, a global dev...
Singapore: Despite concerns around declines in R&D, there would be a surge in global sales in the coming years reach...
Singapore: Amaran Biotechnology is going to invest $33.41 million (NT$1 billion) in order to construct a plant and a res...
Singapore: Australia-based Drawbridge Pharmaceuticals has commenced a phase 1C clinical trial of alphaxalone dissolved i...
Singapore: Australian company Clinuvel Pharmaceuticals reported successful, statistically significant results from its U...
Singapore: A pair of studies by researchers at the Stanford University School of Medicine has identified a molecular pat...
Singapore: Dr Deborah Rathjen, CEO of Australia based Bionomics, was awarded the Life Science Woman Executive of the Yea...
Singapore: A joint study by researchers at the National Neuroscience Institute (NNI), National University of Singapore (...
Singapore: BioDiem received a grant of a Chinese divisional patent, expanding the patent position for its novel antimicr...
Singapore: ChemoCentryx reported that GlaxoSmithKline's (GSK) first-of-four phase III studies, called Shield-1; investig...
Singapore: A research team led by Academia Sinica President, Dr. Chi-Huey Wong, and associate research fellow, Dr Chung-...
Singapore: Australia-based Phylogica recieved allowance of its US patent application for synthetic Phylomer libraries. T...
Singapore: Australian company Mesoblast has outlined the company's strategic plans to develop adult stem cell therapies...
Singapore: Bristol-Myers Squibb (BMS) has suspended study drug administration in an ongoing phase II study of BMS-986094...
Singapore: Australia-based Starpharma reported significant tumor-targeting results with its proprietary dendrimer-doceta...
